A H Jamshidi

ORCID: 0000-0003-1310-1516
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Saffron Plant Research Studies
  • Essential Oils and Antimicrobial Activity
  • Phytochemistry and Biological Activities
  • Pharmacological Effects of Medicinal Plants
  • Plant Physiology and Cultivation Studies
  • Phytochemical and Pharmacological Studies
  • Cholinesterase and Neurodegenerative Diseases
  • Botanical Research and Chemistry
  • Medicinal Plants and Neuroprotection
  • Alzheimer's disease research and treatments
  • Biomedical Research and Pathophysiology
  • Nigella sativa pharmacological applications
  • Medicinal Plants and Bioactive Compounds
  • Edible Oils Quality and Analysis
  • Bee Products Chemical Analysis
  • Hedgehog Signaling Pathway Studies
  • Phytochemistry and biological activities of Ficus species
  • Psidium guajava Extracts and Applications
  • Milk Quality and Mastitis in Dairy Cows
  • Complementary and Alternative Medicine Studies
  • Bioactive natural compounds
  • Insect and Pesticide Research
  • Livestock Farming and Management
  • Toxin Mechanisms and Immunotoxins
  • Cynara cardunculus studies

Iran University of Medical Sciences
2021-2024

Ministry of Health and Medical Education
2006-2017

Ferdowsi University of Mashhad
2012

Tehran University of Medical Sciences
2002-2012

Institute of Medicinal Plant Development
2010-2011

Academic Center for Education, Culture and Research
2002-2010

Iranian Research Institute of Plant Protection
2002-2006

Background: Alzheimer's disease is characterized by a slow, progressive decline in cognitive function and behaviour. Acetylcholine esterase inhibitors are the only agents approved Food Drug Administration for treatment of disease. All other prescribed used on an off-label basis. Current research into new drugs focused that will prevent, slow down and/or halt progress process. Savia officinalis has been herbal medicine many centuries. It suggested, basis traditional medicine, its vitro...

10.1046/j.1365-2710.2003.00463.x article EN Journal of Clinical Pharmacy and Therapeutics 2003-02-01

The morbidity and mortality associated with depression are considerable continue to increase. Depression currently ranks fourth among the major causes of disability worldwide, after lower respiratory infections, prenatal conditions, HIV/AIDS. Crocus sativus L. is used treat depression. Many medicinal plants textbooks refer this indication whereas there no evidence-based document. Our objective was compare efficacy stigmas (saffron) imipramine in treatment mild moderate a 6-week pilot...

10.1186/1472-6882-4-12 article EN cc-by BMC Complementary and Alternative Medicine 2004-09-02

Abstract Depression is a serious disorder in today's society, with estimates of lifetime prevalence as high 21% the general population some developed countries. As therapeutic plant, saffron considered excellent for stomach ailments and an antispasmodic, to help digestion increase appetite. It also used depression Persian traditional medicine. Our objective was assess efficacy stigmas Crocus sativus (saffron) treatment mild moderate 6‐week double‐blind, placebo‐controlled randomized trial....

10.1002/ptr.1647 article EN Phytotherapy Research 2005-02-01

Herbal medicines have been used in the treatment of behavioural and psychological symptoms dementia but with variable response. Crocus sativus (saffron) may inhibit aggregation deposition amyloid β human brain therefore be useful Alzheimer's disease (AD).The goal this study was to assess efficacy saffron mild moderate AD.Forty-six patients probable AD were screened for a 16-week, double-blind parallel groups AD. The psychometric measures, which included assessment scale-cognitive subscale...

10.1111/j.1365-2710.2009.01133.x article EN Journal of Clinical Pharmacy and Therapeutics 2010-06-02

Objective Saffron ( Crocus sativus L.) has shown beneficial aphrodisiac effects in some animal and human studies. The aim of the present study was to assess safety efficacy saffron on selective serotonin reuptake inhibitor‐induced sexual dysfunction women. Methods This a randomized double‐blind placebo‐controlled study. Thirty‐eight women with major depression who were stabilized fluoxetine 40 mg/day for minimum 6 weeks had experienced subjective feeling entered patients randomly assigned...

10.1002/hup.2282 article EN Human Psychopharmacology Clinical and Experimental 2012-12-20
Coming Soon ...